Royal Osteoporosis Society

Activities: Research & Development

Trending Articles

  1. ADM debuts GLP-1 support range backed by consumer insights and preferences The nutraceutical and functional foods provider has curated a range of products suitable for those taking AOMs, taking into account the findings from a US consumer survey
  2. Lesaffre acquires Gingko Bioworks-owned Altar to bolster its fermentation R&D capabilities The company will now be able to better cultivate complex micro-organisms with specific properties with Altar's fermentation technologies
  3. Parry Nutraceuticals' organic spirulina awarded EU import license The approval will enhance the availability of quality and competitively priced microalgae products in Europe
  4. Gateway Health Alliances' weight management ingredients boosts GLP-1 by more than 50% Dyglomera and CQR-300 increased GLP-1 blood levels by 68% and 56%, respectively, after 12 weeks, while reducing body weight by 17% and 14%
  5. Mums that use probiotics can enhance their infant's memory via breastfeeding, study reveals Probiotics can positively benefit an infant via breast milk exposure by boosting their gut microbiome diversity and enhancing their recognition memory

Upcoming event

SupplySide West

28 October - 1st November 2024 | Exhibition | Las Vegas, US See all

Related Content

Research & Development

California Prune Board highlights how bone health affects men

According to statistics from the Royal Osteoporosis Society, one in five men over 50 will suffer from fractures as a result of osteoporosis
Regulatory

California Prune Board and ROS renew partnership

The ROS is the UK’s leading charity dedicated to improving bone health through research, advice, and education
Active Nutrition

Royal Osteoporosis Society recognises The Turmeric Co. for bone health

Osteoporosis causes 500,000 broken bones in the UK every year, costing over £4.5bn
Subscribe now